PULM Archived Articles
Pulmatrix, Inc. (NASDAQ:PULM): Navigating the Transition from Clinical-Stage to Potential Commercialization
Published on March 13, 2025
Pulmatrix (PULM): Turning Inhalation Therapy Innovation into Strategic Opportunities
Published on November 28, 2024
Pulmatrix, Inc. (PULM): Inhaled Therapeutics Specialist Navigating Challenges, Seeking Partnerships to Advance Pipeline
Published on September 24, 2024